Weight loss during neoadjuvant therapy and short-term outcomes after esophagectomy: a retrospective cohort study.
Yuki HiranoTakaaki KonishiHidehiro KanekoHidetaka ItohSatoru MatsudaHirofumi KawakuboKazuaki UdaHiroki MatsuiKiyohide FushimiHiroyuki DaikoOsamu ItanoHideo YasunagaYuko KitagawaPublished in: International journal of surgery (London, England) (2023)
Weight loss during NAT was associated with failure to rescue and in-hospital mortality after esophagectomy, independent of baseline BMI. This emphasizes the importance of weight loss measurement during NAT to assess the risk for a subsequent esophagectomy.
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- gastric bypass
- weight gain
- robot assisted
- rectal cancer
- body mass index
- healthcare
- glycemic control
- lymph node
- squamous cell carcinoma
- emergency department
- metabolic syndrome
- radiation therapy
- type diabetes
- mesenchymal stem cells
- bone marrow
- adverse drug
- electronic health record